PRZOOM - /newswire/ -
Mumbai, Maharashtra, India, 2007/04/06 - Dennis Gillings, CBE, Chairman and CEO of Quintiles Transnational Corp., today dedicated the company’s new central lab in Mumbai, India, and congratulated Quintiles India for its 10 years of growth and leadership in clinical research.
The new lab expands Quintiles’ global central laboratory network and enhances the suite of services offered in India to support global and regional clinical trials. In addition to its central lab and clinical research businesses, Quintiles India offers electrocardiogram (ECG), interactive voice response (IVR) and data management services.
“The opening of this new lab in India symbolizes the rapid growth and achievement of our team here, as well as the acceptance of India as a center for clinical research,” Gillings said. “Since establishing an office in Ahmedabad 10 years ago, we have added offices in Mumbai and Bangalore with a full complement of services, expanded our clinical research staff to 750 and have conducted more than 700 global trials across business lines. We also were involved in the training of hundreds of investigators on Good Clinical Practice guidelines and helped put India on the world map for clinical research.”
Ferzaan Engineer, CEO of Quintiles India, said, “The rapid growth of Quintiles India has been the result of hard work by a dedicated group of people who are focused on meeting the highest standards for quality and customer service. That focus, in turn, has brought more and more global customers to us, and the need to expand our services, including this new central lab.”
Tom Wollman, Senior Vice President, Global Central Laboratories, said the new lab is harmonized with Quintiles’ global network. "The India lab has begun proficiency testing for certification by the College of American Pathologists (CAP), and we look forward to adding another lab with this well-recognized global standard of quality to our global footprint."
The Mumbai lab will provide access to Quintiles laboratory kits, ensure that all study samples are processed using consistent methods and completed in a timely manner, and will oversee the data transfer for inclusion in the Quintiles Laboratory Information Management System (QLIMS) and the protocol-specific database.
About Quintiles Laboratories
Quintiles Laboratories (quintilesmumbailab.com) owns a network of clinically harmonized facilities in the U.S., Europe, South Africa, India, China and Singapore, and has a tightly controlled network of sub-contractor laboratories in Argentina and Brazil managed by Quintiles employees located in each of the sub-contractor facilities.
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the biotechnology and healthcare industries. With 17,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry.